The Coalition for Health AI (CHAI) is launching PULSE—a massive testing ground where ten US health departments will deploy enterprise licenses for OpenAI and Anthropic. This is more than just another attempt to help bureaucrats draft emails faster. We are looking at the deep integration of neural networks into biosurveillance, clinical data analysis via the FHIR standard, and even predictive modeling for opioid epidemics. The project has allocated 2,000 seats, with consulting giant Accenture serving as the "translator" bridging the gap between startup culture and government bureaucracy.
Project PULSE represents AI labs moving out of the sandbox and into the real world, where the cost of a model hallucination is measured in lives rather than broken code. Judging by the stated objectives, Sam Altman and Dario Amodei plan to use their models for strictly utilitarian purposes: translation, summarization, and searching through massive datasets to fill staffing gaps and compensate for the chronic time shortages faced by public servants. Notably, the public playbooks resulting from this experiment are not scheduled for release until 2027. This is a classic long game, with OpenAI and Anthropic shaping industry safety standards under the watchful eye of seasoned integrators.
Key highlights of the initiative
2,000 enterprise licenses across ten regional health departments. Focus on high-stakes tasks: biosurveillance and FHIR data processing. Accenture acts as the primary systems integrator and buffer. Results and best practices will be codified into public playbooks by 2027.
This looks like a massive data-gathering exercise to identify exactly where the much-vaunted LLMs break when they collide with conservative medical realities.
While the mechanics are logical, they are also pointedly cautious. Performance metrics have only been partially disclosed, and the project is framed as a series of pilots that do not—under any circumstances—replace physician decision-making. As Accenture carefully stitches these models into the existing state apparatus, we are witnessing the legalization of AI within America’s most strictly regulated structures. Instead of the hyped revolution, we get a methodical, bureaucratically calibrated beta test hidden behind the veil of public benefit.